© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to November
5-HT2 antagonist and 5-HT7 inverse agonist
brain penetrant, oral efficacy in rodent models
backup candidate to JNJ-18038683
Bioorg. Med. Chem. Lett., Nov. 7, 2020
Janssen, San Diego, CA
“compound 4j” (Janssen (JNJ) brain-penetrant in vivo 5-HT2 antagonist and 5-HT7 inverse agonist, backup candidate)
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.